-transparent.png){kind=logo}
We describe molecular prenatal diagnosis and carrier detection of tyrosinase-negative oculocutaneous albinism (OCA1A) in two families. In one family, we carried out DNA-based prenatal diagnosis of OCA1A. In the other family, mutation analysis and carrier detection obviated the need for prenatal diagnosis. Molecular analysis is safer and probably more accurate than fetoscopy and fetal scalp biopsy, and should become the method of first choice for prenatal diagnosis of OCA1.
Related Publications
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
September 1992,
Lancet (London, England),
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
January 1997,
Acta dermato-venereologica,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
December 1997,
The Japanese journal of human genetics,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
March 1977,
American journal of human genetics,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
July 1994,
The Journal of investigative dermatology,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
February 1984,
Documenta ophthalmologica. Advances in ophthalmology,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
June 1994,
Prenatal diagnosis,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
January 1992,
Pigment cell research,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
January 1995,
Archives of dermatological research,
T C Falik-Borenstein, and
S A Holmes, and
Z Borochowitz, and
A Levin, and
A Rosenmann, and
R A Spritz
November 1992,
Human genetics,
